Bronchitis, Chronic
27
0
1
22
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
7.4%
2 terminated out of 27 trials
91.7%
+5.2% vs benchmark
37%
10 trials in Phase 3/4
5%
1 of 22 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 22 completed trials
Clinical Trials (27)
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Airway Macrophages and Sputum Milieu in Adult Subjects With Airflow Obstruction
Safety and Feasibility Study of Rejuvenair™ for Treating Chronic Bronchitis Patients
Effect of BIBW 2948 BS in COPD
eRT Remote Health Monitoring
Is the Short Physical Performance Battery a Useful Outcome Measure in Chronic Obstructive Pulmonary Disease
Eccentric Exercise Training as Novel Rehabilitation for Chronic Obstructive Pulmonary Disease (COPD)
Innate Immune Response in COPD
Post-hospitalisation Nutritional Support and Gait Speed in COPD
Mucolytic Effectiveness of Tacholiquine ® in Chronic Bronchitis
Outpatient Registry Trial of Respiratory Tract Infections in Adults
Physical Activity Augmentation Using Pedometers During Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease
Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbation if COPD?
Intermittent Moxifloxacin Therapy For The Prevention Of Acute Exacerbations In Patients With Chronic Bronchitis
Safety and Efficacy of 4-weeks Treatment of BIBW 2948 BS in Patients With Chronic Obstructive Bronchitis
Greatest International Antiinfective Trial With Avelox
AVANTI - Avelox® in Acute Exacerbations of chroNic bronchiTIs
Telithromycin: in the Treatment of Acute Exacerbation of Chronic Bronchitis in Adult Outpatients With COPD
A Study of the Safety and Effectiveness of Levofloxacin Compared With Cefaclor in the Treatment of Adults With Chronic Bronchitis Experiencing Rapid Onset of Worsening of Symptoms Caused by Bacteria
A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Cefuroxime Axetil in the Treatment of Adults With Persistent Bronchitis Experiencing Rapid Onset of Severe Worsening of Symptoms Caused by Bacteria